Clinical trial
A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Activity of Single Ascending Doses of SBT777101 in Subjects With Hidradenitis Suppurativa
NCT06361836 is registered in ClinicalTrials.gov with Sonoma Biotherapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Activity of Single Ascending Doses of SBT777101 in Subjects With Hidradenitis Suppurativa
- Lead sponsor
- Sonoma Biotherapeutics, Inc.
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- October 9, 2024
- Completion date
- November 30, 2026
- Enrollment
- 24 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.